Clinical Trial Update: Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a combination immunotherapy for metastatic microsatellite-stable colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Dan Feng | Conditions: Metastatic Microsatellite Stable Colorectal Carcinoma | Phase 1, Phase 2 | Status: RECRUITING